{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T05:57:51Z","timestamp":1775109471493,"version":"3.50.1"},"reference-count":198,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Preventive Cardiology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ajpc.2025.101361","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T16:14:10Z","timestamp":1764346450000},"page":"101361","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Racial and ethnic disparities in the management of risk factors in individuals with atrial fibrillation: A narrative review"],"prefix":"10.1016","volume":"25","author":[{"given":"Anthony","family":"D\u2019Oro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zoee","family":"D\u2019Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jasmyn J.","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Min","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"II","given":"Larry R.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4494-5028","authenticated-orcid":false,"given":"Utibe R.","family":"Essien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.ajpc.2025.101361_bib0001","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/j.jacc.2024.07.014","article-title":"Minimum national prevalence of diagnosed atrial fibrillation inferred from California Acute Care facilities","volume":"84","author":"Noubiap","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpc.2025.101361_bib0002","article-title":"Atrial fibrillation: epidemiology, screening and digital health","volume":"37","author":"Linz","year":"2024","journal-title":"Lancet reg health Eur"},{"issue":"9989","key":"10.1016\/j.ajpc.2025.101361_bib0003","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0140-6736(14)61774-8","article-title":"50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study","volume":"386","author":"Schnabel","year":"2015","journal-title":"Lancet (Br ed)"},{"issue":"11","key":"10.1016\/j.ajpc.2025.101361_bib0004","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/j.amjcard.2009.07.022","article-title":"Increasing prevalence of atrial fibrillation and flutter in the United States","volume":"104","author":"Naccarelli","year":"2009","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1016\/j.ajpc.2025.101361_bib0005","first-page":"e21","article-title":"Heart Disease and Stroke Statistics\u20132009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee","volume":"119","author":"Lloyd-Jones","year":"2009","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ajpc.2025.101361_bib0006","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1161\/CIRCOUTCOMES.110.958165","article-title":"Estimation of total incremental health care costs in patients with atrial fibrillation in the United States","volume":"4","author":"Kim","year":"2011","journal-title":"Circ Cardiovasc qual outcomes"},{"issue":"4","key":"10.1016\/j.ajpc.2025.101361_bib0007","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1001\/jamacardio.2016.1259","article-title":"The \u201cdouble\u201d paradox of atrial fibrillation in black individuals","volume":"1","author":"Stamos","year":"2016","journal-title":"JAMA cardiol"},{"issue":"1","key":"10.1016\/j.ajpc.2025.101361_bib0008","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.119.007698","article-title":"Differences by race\/ethnicity in the prevalence of clinically detected and monitor-detected atrial fibrillation: MESA","volume":"13","author":"Heckbert","year":"2020","journal-title":"Circ Arrhythmia electrophysiol"},{"issue":"5","key":"10.1016\/j.ajpc.2025.101361_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.104718","article-title":"Racial disparity in the prescription of anticoagulants and risk of stroke and bleeding in atrial fibrillation patients","volume":"29","author":"Tedla","year":"2020","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"2","key":"10.1016\/j.ajpc.2025.101361_bib0010","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.amjcard.2015.04.012","article-title":"Effect of race on outcomes (Stroke and Death) in patients >65 years with atrial fibrillation","volume":"116","author":"Kabra","year":"2015","journal-title":"Am J Cardiol"},{"issue":"10","key":"10.1016\/j.ajpc.2025.101361_bib0011","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1161\/STROKEAHA.110.589127","article-title":"Mexican Americans with atrial fibrillation have more recurrent strokes than do Non-Hispanic whites","volume":"41","author":"Simpson","year":"2010","journal-title":"Stroke (1970)"},{"issue":"4","key":"10.1016\/j.ajpc.2025.101361_bib0012","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1001\/jamacardio.2016.1025","article-title":"Racial differences in atrial fibrillation-related cardiovascular disease and mortality: the atherosclerosis risk in communities (ARIC) study","volume":"1","author":"Magnani","year":"2016","journal-title":"JAMA cardiol"},{"key":"10.1016\/j.ajpc.2025.101361_bib0013","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.amjcard.2022.10.039","article-title":"Racial differences in atrial fibrillation management between white patients and black patients in Transthyretin Cardiac Amyloid","volume":"187","author":"Mitrani","year":"2023","journal-title":"Am J Cardiol"},{"issue":"7","key":"10.1016\/j.ajpc.2025.101361_bib0014","article-title":"Association of race and ethnicity with stroke and mortality outcomes in atrial fibrillation","volume":"4","author":"Essien","year":"2025","journal-title":"JACC Adv (Online)"},{"issue":"1","key":"10.1016\/j.ajpc.2025.101361_bib0015","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1161\/CIRCRESAHA.120.316340","article-title":"Epidemiology of atrial fibrillation in the 21st century: novel methods and new insights","volume":"127","author":"Kornej","year":"2020","journal-title":"Circ Res"},{"issue":"12","key":"10.1016\/j.ajpc.2025.101361_bib0016","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1001\/jamacardio.2018.3945","article-title":"Association of race\/ethnicity with oral anticoagulant use in patients with atrial fibrillation: findings from the outcomes registry for better informed treatment of atrial fibrillation II","volume":"3","author":"Essien","year":"2018","journal-title":"JAMA cardiol"},{"issue":"7","key":"10.1016\/j.ajpc.2025.101361_bib0017","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.14234","article-title":"Disparities in anticoagulant therapy initiation for incident atrial fibrillation by race\/ethnicity among patients in the Veterans Health Administration System","volume":"4","author":"Essien","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"6","key":"10.1016\/j.ajpc.2025.101361_bib0018","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1161\/STROKEAHA.118.023959","article-title":"Disparities and temporal trends in the use of anticoagulation in patients with ischemic stroke and atrial fibrillation","volume":"50","author":"Sur","year":"2019","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.ajpc.2025.101361_bib0019","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.9465","article-title":"Racial and ethnic disparities in initiation of direct oral anticoagulants among Medicare beneficiaries","volume":"7","author":"Reynolds","year":"2024","journal-title":"JAMA netw open"},{"issue":"7","key":"10.1016\/j.ajpc.2025.101361_bib0020","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.amjcard.2016.01.040","article-title":"Gender, race, and health insurance status in patients undergoing catheter ablation for atrial fibrillation","volume":"117","author":"Patel","year":"2016","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ajpc.2025.101361_bib0021","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ahj.2015.10.028","article-title":"Racial\/ethnic differences in atrial fibrillation symptoms, treatment patterns, and outcomes: insights from Outcomes Registry for better informed treatment for Atrial fibrillation Registry","volume":"174","author":"Golwala","year":"2016","journal-title":"Am Heart J"},{"issue":"2","key":"10.1016\/j.ajpc.2025.101361_bib0022","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.0247","article-title":"Racial\/ethnic and socioeconomic disparities in management of incident paroxysmal atrial fibrillation","volume":"4","author":"Eberly","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"2","key":"10.1016\/j.ajpc.2025.101361_bib0023","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jacc.2021.04.092","article-title":"Ablation versus drug therapy for atrial fibrillation in racial and ethnic minorities","volume":"78","author":"Thomas","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.ajpc.2025.101361_bib0024","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.hrthm.2024.06.052","article-title":"Inequities in atrial fibrillation trials: an analysis of participant race, ethnicity, and sex over time","volume":"22","author":"Lan","year":"2025","journal-title":"Heart rhythm"},{"issue":"19","key":"10.1016\/j.ajpc.2025.101361_bib0025","doi-asserted-by":"crossref","first-page":"e163","DOI":"10.1016\/j.jacc.2021.08.054","article-title":"Racial and ethnic representation in atrial fibrillation trials: CABANA and beyond","volume":"78","author":"Tertulien","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.ajpc.2025.101361_bib0026","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.jacep.2020.03.001","article-title":"Under-reporting and Under-representation of racial\/ethnic minorities in major atrial fibrillation clinical trials","volume":"6","author":"Sarraju","year":"2020","journal-title":"JACC Clin electrophysiol"},{"issue":"2","key":"10.1016\/j.ajpc.2025.101361_bib0027","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s11239-014-1145-7","article-title":"Review of race\/ethnicity in non vitamin K antagonist oral anticoagulants clinical trials","volume":"39","author":"Jackson","year":"2015","journal-title":"J Thromb Thrombolysis"},{"issue":"13","key":"10.1016\/j.ajpc.2025.101361_bib0028","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1001\/jama.2019.0693","article-title":"Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation: the CABANA randomized clinical trial","volume":"321","author":"Packer","year":"2019","journal-title":"JAMA: j Am Med Assoc"},{"issue":"9","key":"10.1016\/j.ajpc.2025.101361_bib0029","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1111\/j.1540-8167.2011.02043.x","article-title":"Demographic profile of patients undergoing catheter ablation of atrial fibrillation","volume":"22","author":"Hoyt","year":"2011","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"25","key":"10.1016\/j.ajpc.2025.101361_bib0030","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1016\/j.jacc.2021.04.110","article-title":"Racial and ethnic considerations in patients with atrial fibrillation: JACC Focus Seminar 5\/9","volume":"78","author":"Norby","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.ajpc.2025.101361_bib0031","first-page":"e1","article-title":"2023 ACC\/AHA\/ACCP\/HRS Guideline for the Diagnosis and Management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"149","author":"Joglar","year":"2024","journal-title":"Circ (N Y NY)"},{"issue":"5","key":"10.1016\/j.ajpc.2025.101361_bib0032","first-page":"1198","article-title":"AGA clinical practice guideline on pharmacological interventions for adults with obesity","volume":"163","author":"Grunvald","year":"2022","journal-title":"Gastroenterol (N Y NY 1943)"},{"key":"10.1016\/j.ajpc.2025.101361_bib0033","article-title":"Trends in obesity and adiposity measures by race or ethnicity among adults in the United States 2011-18: population based study","volume":"372","author":"Liu","year":"2021","journal-title":"BMJ"},{"issue":"23","key":"10.1016\/j.ajpc.2025.101361_bib0034","first-page":"2538","article-title":"Relations of left ventricular mass to fat-free and adipose body mass: the strong heart study. The Strong Heart Study Investigators","volume":"98","author":"Bella","year":"1998","journal-title":"Circ (N Y NY)"},{"issue":"1","key":"10.1016\/j.ajpc.2025.101361_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2015.04.058","article-title":"Electrophysiological, electroanatomical, and structural remodeling of the atria as consequences of sustained obesity","volume":"66","author":"Mahajan","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.ajpc.2025.101361_bib0036","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s10554-013-0317-4","article-title":"New inflammatory predictors for non-valvular atrial fibrillation: echocardiographic epicardial fat thickness and neutrophil to lymphocyte ratio","volume":"30","author":"Acet","year":"2014","journal-title":"Int J Cardiovasc Imaging"},{"issue":"12","key":"10.1016\/j.ajpc.2025.101361_bib0037","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.116.004378","article-title":"Associations of epicardial, abdominal, and overall adiposity with atrial fibrillation","volume":"9","author":"Wong","year":"2016","journal-title":"Circ Arrhythmia electrophysiol"},{"issue":"1","key":"10.1016\/j.ajpc.2025.101361_bib0038","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.032277","article-title":"Impact of obesity on atrial fibrillation pathogenesis and treatment options","volume":"13","author":"Sha","year":"2024","journal-title":"J Am Heart Assoc"},{"issue":"7","key":"10.1016\/j.ajpc.2025.101361_bib0039","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.amjmed.2009.11.026","article-title":"Influence of obesity on outcomes in atrial fibrillation: yet another obesity paradox","volume":"123","author":"Badheka","year":"2010","journal-title":"Am J Med"},{"issue":"19","key":"10.1016\/j.ajpc.2025.101361_bib0040","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1093\/eurheartj\/ehy861","article-title":"Relationship between body mass index and outcomes in patients with atrial fibrillation treated with edoxaban or warfarin in the ENGAGE AF-TIMI 48 trial","volume":"40","author":"Boriani","year":"2019","journal-title":"Eur Heart J"},{"issue":"7","key":"10.1016\/j.ajpc.2025.101361_bib0041","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjmed.2012.11.024","article-title":"Body mass index and adverse events in patients with incident atrial fibrillation","volume":"126","author":"Overvad","year":"2013","journal-title":"Am J Med"},{"issue":"20","key":"10.1016\/j.ajpc.2025.101361_bib0042","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/j.jacc.2015.03.002","article-title":"Long-term effect of goal-directed weight management in an atrial fibrillation cohort: a Long-term follow-up study (LEGACY)","volume":"65","author":"Pathak","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.ajpc.2025.101361_bib0043","first-page":"1548","article-title":"Supervised Obesity Reduction Trial for AF ablation patients: results from the SORT-AF trial","volume":"23","author":"Gessler","year":"2021","journal-title":"Eur (L Engl)"},{"issue":"19","key":"10.1016\/j.ajpc.2025.101361_bib0044","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1001\/jama.2013.280521","article-title":"Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial","volume":"310","author":"Abed","year":"2013","journal-title":"JAMA: j Am Med Assoc"},{"issue":"12","key":"10.1016\/j.ajpc.2025.101361_bib0045","first-page":"1929","article-title":"PREVEntion and regReSsive effect of weight-loss and risk factor modification on Atrial fibrillation: the REVERSE-AF study","volume":"20","author":"Middeldorp","year":"2018","journal-title":"EP Eur"},{"issue":"25_suppl_2 Suppl 1","key":"10.1016\/j.ajpc.2025.101361_bib0046","first-page":"S102","article-title":"2013 AHA\/ACC\/TOS Guideline for the management of overweight and Obesity in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and The Obesity Society","volume":"129","author":"Jensen","year":"2014","journal-title":"Circ (N Y NY)"},{"issue":"2","key":"10.1016\/j.ajpc.2025.101361_bib0047","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/cob.12180","article-title":"Behavioural treatment strategies improve adherence to lifestyle intervention programmes in adults with obesity: a systematic review and meta-analysis","volume":"7","author":"Burgess","year":"2017","journal-title":"Clin Obes"},{"issue":"10","key":"10.1016\/j.ajpc.2025.101361_bib0048","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1056\/NEJMoa2007448","article-title":"Weight loss in underserved patients \u2014 A cluster-randomized trial","volume":"383","author":"Katzmarzyk","year":"2020","journal-title":"N Engl J Med"},{"issue":"14","key":"10.1016\/j.ajpc.2025.101361_bib0049","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.1007\/s11606-022-07521-5","article-title":"Differences in weight loss by race and ethnicity in the PRIDE Trial: a qualitative analysis of participant perspectives","volume":"37","author":"Saju","year":"2022","journal-title":"J gen intern med: JGIM"},{"issue":"11","key":"10.1016\/j.ajpc.2025.101361_bib0050","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1176\/appi.ps.201300404","article-title":"Weight loss after participation in a national VA Weight management program among veterans with or without PTSD","volume":"65","author":"Hoerster","year":"2014","journal-title":"Psychiatr serv (Wash DC)"},{"issue":"6","key":"10.1016\/j.ajpc.2025.101361_bib0051","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1038\/oby.2008.224","article-title":"Weight loss of black, white, and Hispanic men and women in the diabetes prevention program","volume":"16","author":"West","year":"2008","journal-title":"Obes (Silver Spring Md)"},{"issue":"4","key":"10.1016\/j.ajpc.2025.101361_bib0052","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s11606-023-08501-z","article-title":"Real world use of anti-obesity medications and weight change in veterans","volume":"39","author":"Hung","year":"2024","journal-title":"J gen intern med: JGIM"},{"issue":"508","key":"10.1016\/j.ajpc.2025.101361_bib0053","article-title":"Obesity and severe Obesity prevalence in adults: united States, August 2021-August 2023","author":"Emmerich","year":"2024","journal-title":"NCHS data br"},{"issue":"Issue 1","key":"10.1016\/j.ajpc.2025.101361_bib0054","first-page":"305","article-title":"Pharmacotherapy for obesity: recent updates","volume":"17","author":"Fredrick","year":"2025","journal-title":"Clin pharmacol: adv appl"},{"issue":"1","key":"10.1016\/j.ajpc.2025.101361_bib0055","first-page":"103","article-title":"Race\/ethnicity and sex-related differences in direct oral anticoagulant initiation in newly diagnosed atrial fibrillation: a retrospective study of Medicare data","volume":"112","author":"Essien","year":"2020","journal-title":"J Natl Med Assoc"},{"issue":"12","key":"10.1016\/j.ajpc.2025.101361_bib0056","doi-asserted-by":"crossref","DOI":"10.1001\/jamahealthforum.2021.4182","article-title":"Racial, ethnic, and socioeconomic inequities in glucagon-like peptide-1 receptor agonist use among patients with diabetes in the US","volume":"2","author":"Eberly","year":"2021","journal-title":"JAMA health forum"},{"issue":"1","key":"10.1016\/j.ajpc.2025.101361_bib0057","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s00125-024-06321-2","article-title":"Racial and ethnic disparities in the uptake of SGLT2is and GLP-1RAs among Medicare beneficiaries with type 2 diabetes and heart failure, atherosclerotic cardiovascular disease and chronic kidney disease, 2013\u20132019","volume":"68","author":"Wang","year":"2025","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.ajpc.2025.101361_bib0058","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.124.011649","article-title":"Racial and ethnic differences in semaglutide prescriptions for Veterans with overweight or obesity in the Veterans Affairs Healthcare System","volume":"18","author":"Tisdale","year":"2025","journal-title":"Circ Cardiovasc qual outcomes"},{"issue":"19","key":"10.1016\/j.ajpc.2025.101361_bib0059","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.ajpc.2025.101361_bib0060","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1111\/dom.13805","article-title":"Do GLP-1RAs and SGLT-2is reduce cardiovascular events in black patients with type 2 diabetes? A systematic review and meta-analysis","volume":"21","author":"Mishriky","year":"2019","journal-title":"Diabetes Obes Metab"},{"issue":"12","key":"10.1016\/j.ajpc.2025.101361_bib0061","doi-asserted-by":"crossref","DOI":"10.1111\/eci.14292","article-title":"Glucagon-like peptide-1 receptor agonist semaglutide reduces atrial fibrillation incidence: a systematic review and meta-analysis","volume":"54","author":"Saglietto","year":"2024","journal-title":"Eur J Clin Invest"},{"issue":"10","key":"10.1016\/j.ajpc.2025.101361_bib0062","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.1007\/s12325-024-02959-x","article-title":"Effects of glucagon-like peptide 1 receptor agonists on atrial fibrillation recurrence after catheter ablation: a systematic review and meta-analysis","volume":"41","author":"Karakasis","year":"2024","journal-title":"Adv Ther"},{"issue":"19","key":"10.1016\/j.ajpc.2025.101361_bib0063","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1016\/j.jacc.2017.11.006","volume":"71","author":"Whelton","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.ajpc.2025.101361_bib0064","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ahj.2013.10.023","article-title":"Association of all-cause and cardiovascular mortality with prehypertension: a meta-analysis","volume":"167","author":"Huang","year":"2014","journal-title":"Am heart j"},{"issue":"6","key":"10.1016\/j.ajpc.2025.101361_bib0065","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s11906-013-0403-y","article-title":"Association between Pre-hypertension and cardiovascular outcomes: a systematic review and meta-analysis of prospective studies","volume":"15","author":"Guo","year":"2013","journal-title":"Curr Hypertens Rep"},{"issue":"10","key":"10.1016\/j.ajpc.2025.101361_bib0066","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0002-9149(03)00227-3","article-title":"Atrial fibrillation: hypertension as a causative agent, risk factor for complications, and potential therapeutic target","volume":"91","author":"Healey","year":"2003","journal-title":"Am J Cardiol"},{"issue":"7","key":"10.1016\/j.ajpc.2025.101361_bib0067","doi-asserted-by":"crossref","first-page":"2N","DOI":"10.1016\/S0002-9149(98)00583-9","article-title":"Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates","volume":"82","author":"Kannel","year":"1998","journal-title":"Am J Cardiol"},{"issue":"23","key":"10.1016\/j.ajpc.2025.101361_bib0068","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1161\/01.CIR.0000072793.81076.D4","article-title":"Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the studies of left ventricular dysfunction (SOLVD) trials","volume":"107","author":"Vermes","year":"2003","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ajpc.2025.101361_bib0069","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1161\/HYPERTENSIONAHA.115.05728","article-title":"Effect of lower on-treatment systolic blood pressure on the risk of atrial fibrillation in hypertensive patients","volume":"66","author":"Okin","year":"2015","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.ajpc.2025.101361_bib0070","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1161\/HYPERTENSIONAHA.120.14766","article-title":"Effect of intensive blood pressure lowering on the risk of atrial fibrillation","volume":"75","author":"Soliman","year":"2020","journal-title":"Hypertension"},{"issue":"11","key":"10.1016\/j.ajpc.2025.101361_bib0071","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1002\/clc.24135","article-title":"Association of hypertension severity and control with risk of incident atrial fibrillation: the REasons for geographic and racial differences in stroke (REGARDS) study","volume":"46","author":"Garg","year":"2023","journal-title":"Clin cardiol (Mahwah NJ)"},{"issue":"12","key":"10.1016\/j.ajpc.2025.101361_bib0072","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002015","article-title":"Blood pressure control and risk of stroke or systemic embolism in patients with atrial fibrillation: results from the Apixaban for reduction in stroke and other thromboembolic events in atrial fibrillation (ARISTOTLE) trial","volume":"4","author":"Rao","year":"2015","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ajpc.2025.101361_bib0073","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.amjcard.2022.06.036","article-title":"Controlled level and variability of systolic blood pressure on the risk of thromboembolic events in atrial fibrillation and hypertension","volume":"180","author":"Kim","year":"2022","journal-title":"Am J Cardiol"},{"issue":"12","key":"10.1016\/j.ajpc.2025.101361_bib0074","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1001\/jama.2020.14545","article-title":"Trends in blood pressure control among US adults with hypertension, 1999-2000 to 2017-2018","volume":"324","author":"Muntner","year":"2020","journal-title":"JAMA: j Am Med Assoc"},{"issue":"6","key":"10.1016\/j.ajpc.2025.101361_bib0075","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1161\/HYPERTENSIONAHA.121.17570","article-title":"Racial\/ethnic disparities in hypertension prevalence, awareness, treatment, and control in the United States, 2013 to 2018","volume":"78","author":"Aggarwal","year":"2021","journal-title":"Hypertens (Dallas Tex 1979)"},{"issue":"131","key":"10.1016\/j.ajpc.2025.101361_bib0076","first-page":"1","article-title":"Prevalence of obesity among adults: united States, 2011-2012","author":"Ogden","year":"2013","journal-title":"NCHS data br"},{"issue":"11","key":"10.1016\/j.ajpc.2025.101361_bib0077","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.3390\/ijerph21111480","article-title":"Economic and cultural assessment of the DASH eating Plan for low-income African Americans: an integrative review","volume":"21","author":"White","year":"2024","journal-title":"Int J Env Res Public Health"},{"issue":"4","key":"10.1016\/j.ajpc.2025.101361_bib0078","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1353\/hpu.2011.0142","article-title":"A multilevel assessment of barriers to adoption of dietary approaches to stop hypertension (DASH) among African Americans of low socioeconomic status","volume":"22","author":"Bertoni","year":"2011","journal-title":"J Health Care Poor Underserved"},{"issue":"6","key":"10.1016\/j.ajpc.2025.101361_bib0079","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.amepre.2015.07.017","article-title":"Food access, chronic kidney disease, and hypertension in the U.S","volume":"49","author":"Suarez","year":"2015","journal-title":"Am J Prev Med"},{"issue":"1","key":"10.1016\/j.ajpc.2025.101361_bib0080","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10460-022-10340-3","article-title":"Redlining, racism and food access in US urban cores","volume":"40","author":"Shaker","year":"2023","journal-title":"Agric Hum Values"},{"issue":"1","key":"10.1016\/j.ajpc.2025.101361_bib0081","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0749-3797(99)00105-1","article-title":"Race\/ethnicity, social class and their relation to physical inactivity during leisure time: results from the Third National Health and Nutrition Examination Survey, 1988\u20131994","volume":"18","author":"Crespo","year":"2000","journal-title":"Am J Prev Med"},{"issue":"1","key":"10.1016\/j.ajpc.2025.101361_bib0082","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1161\/HYPERTENSIONAHA.121.18381","article-title":"National trends in racial and ethnic disparities in antihypertensive medication use and blood pressure control among adults with hypertension, 2011\u20132018","volume":"79","author":"Lu","year":"2022","journal-title":"Hypertens (Dallas Tex 1979)"},{"issue":"6","key":"10.1016\/j.ajpc.2025.101361_bib0083","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1093\/ajh\/hpac011","article-title":"Blood pressure control among Non-Hispanic black adults is lower than Non-Hispanic white adults despite similar treatment with antihypertensive medication: NHANES 2013\u20132018","volume":"35","author":"Hayes","year":"2022","journal-title":"Am J Hypertens"},{"issue":"21","key":"10.1016\/j.ajpc.2025.101361_bib0084","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/j.jacc.2014.09.028","article-title":"Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: the ARREST-AF cohort study","volume":"64","author":"Pathak","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpc.2025.101361_bib0085","doi-asserted-by":"crossref","DOI":"10.1001\/jamacardio.2025.4007","article-title":"Aggressive risk factor reduction study for atrial fibrillation implications for ablation outcomes: the ARREST-AF randomized clinical trial","author":"Pathak","year":"2025","journal-title":"JAMA cardiol"},{"key":"10.1016\/j.ajpc.2025.101361_bib0086","unstructured":"WHO. Diabetes. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/diabetes."},{"key":"10.1016\/j.ajpc.2025.101361_bib0087","unstructured":"CDC. National diabetes Statistics Report. https:\/\/www.cdc.gov\/diabetes\/php\/data-research\/index.html."},{"key":"10.1016\/j.ajpc.2025.101361_bib0088","unstructured":"Association AD. Statistics about diabetes. https:\/\/diabetes.org\/about-diabetes\/statistics\/about-diabetes."},{"key":"10.1016\/j.ajpc.2025.101361_bib0089","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2025.112112","article-title":"Trends and disparities in diabetes mellitus and atrial fibrillation related mortality in the United States: 1999\u20132020","volume":"223","author":"Sohail","year":"2025","journal-title":"Diabetes Res Clin Pr"},{"issue":"8","key":"10.1016\/j.ajpc.2025.101361_bib0090","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s11606-010-1340-y","article-title":"Diabetes mellitus, glycemic control, and risk of atrial fibrillation","volume":"25","author":"Dublin","year":"2010","journal-title":"J gen intern med: JGIM"},{"issue":"3","key":"10.1016\/j.ajpc.2025.101361_bib0091","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ijcard.2005.02.050","article-title":"Diabetes mellitus is a strong, independent risk for atrial fibrillation and flutter in addition to other cardiovascular disease","volume":"105","author":"Movahed","year":"2005","journal-title":"Int J Cardiol"},{"issue":"1","key":"10.1016\/j.ajpc.2025.101361_bib0092","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4103\/0975-3583.59978","article-title":"The link between diabetes and atrial fibrillation: cause or correlation?","volume":"1","author":"Sun","year":"2010","journal-title":"J Cardiovasc Dis Res"},{"issue":"1","key":"10.1016\/j.ajpc.2025.101361_bib0093","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1177\/2047487316676037","volume":"24","author":"Gorenek","year":"2017","journal-title":"Eur J Prev Cardiol"},{"issue":"4","key":"10.1016\/j.ajpc.2025.101361_bib0094","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1001\/jamacardio.2016.5224","article-title":"Atrial fibrillation, type 2 diabetes, and non\u2013Vitamin K antagonist oral anticoagulants: a review","volume":"2","author":"Plitt","year":"2017","journal-title":"JAMA cardiol"},{"issue":"8","key":"10.1016\/j.ajpc.2025.101361_bib0095","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.3390\/jcm12082868","article-title":"Atrial fibrillation and diabetes mellitus: dangerous liaisons or innocent bystanders?","volume":"12","author":"Lorenzo-Almor\u00f3s","year":"2023","journal-title":"J Clin Med"},{"issue":"16","key":"10.1016\/j.ajpc.2025.101361_bib0096","doi-asserted-by":"crossref","first-page":"e750","DOI":"10.1161\/CIR.0000000000000748","article-title":"Lifestyle and risk factor modification for reduction of atrial fibrillation: a scientific statement from the American Heart Association","volume":"141","author":"Chung","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2025.101361_bib0097","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2019.00135","article-title":"The Association between Diabetes Mellitus and Atrial Fibrillation: clinical and mechanistic insights","volume":"10","author":"Bohne","year":"2019","journal-title":"Front Physiol"},{"key":"10.1016\/j.ajpc.2025.101361_bib0098","article-title":"Diabetes and atrial fibrillation: insight from basic to translational science into the mechanisms and management","author":"Kantharia","year":"2025","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"10","key":"10.1016\/j.ajpc.2025.101361_bib0099","first-page":"1455","article-title":"EHRA\/HRS\/APHRS\/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication","volume":"18","author":"Goette","year":"2016","journal-title":"Eur (L Engl)"},{"issue":"12","key":"10.1016\/j.ajpc.2025.101361_bib0100","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13734","article-title":"Advanced glycation end products induce senescence of atrial myocytes and increase susceptibility of atrial fibrillation in diabetic mice","volume":"21","author":"Zheng","year":"2022","journal-title":"Aging cell"},{"issue":"2","key":"10.1016\/j.ajpc.2025.101361_bib0101","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41569-018-0080-2","article-title":"Prevention of atherothrombotic events in patients with diabetes mellitus: from antithrombotic therapies to new-generation glucose-lowering drugs","volume":"16","author":"Patti","year":"2019","journal-title":"Nat rev cardiol"},{"issue":"1","key":"10.1016\/j.ajpc.2025.101361_bib0102","doi-asserted-by":"crossref","DOI":"10.1186\/s12933-021-01232-7","article-title":"Prognostic significance of diabetes mellitus in patients with atrial fibrillation","volume":"20","author":"Papazoglou","year":"2021","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.ajpc.2025.101361_bib0103","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.amjcard.2020.06.049","article-title":"Impact of diabetes mellitus on stroke and survival in patients with atrial fibrillation","volume":"131","author":"Patlolla","year":"2020","journal-title":"Am J Cardiol"},{"issue":"11","key":"10.1016\/j.ajpc.2025.101361_bib0104","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.jacc.2017.07.755","article-title":"Care patterns and outcomes in atrial fibrillation patients with and without diabetes: ORBIT-AF registry","volume":"70","author":"Echouffo-Tcheugui","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.ajpc.2025.101361_bib0105","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.jacc.2019.07.020","article-title":"Atrial fibrillation and diabetes mellitus: JACC review topic of the week","volume":"74","author":"Wang","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.ajpc.2025.101361_bib0106","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.2337\/dc22-0717","article-title":"Associations of new-onset atrial fibrillation with risks of cardiovascular disease, chronic kidney disease, and mortality among patients with type 2 diabetes","volume":"45","author":"Geng","year":"2022","journal-title":"Diabetes care"},{"key":"10.1016\/j.ajpc.2025.101361_bib0107","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2023.110626","article-title":"Association between antidiabetic drugs and the incidence of atrial fibrillation in patients with type 2 diabetes: a nationwide cohort study in South Korea","volume":"198","author":"Kim","year":"2023","journal-title":"Diabetes Res Clin Pr"},{"issue":"15","key":"10.1016\/j.ajpc.2025.101361_bib0108","first-page":"1227","article-title":"Effect of Dapagliflozin on atrial fibrillation in patients with type 2 diabetes mellitus: insights from the DECLARE-TIMI 58 trial","volume":"141","author":"Zelniker","year":"2020","journal-title":"Circ (N Y NY)"},{"issue":"1","key":"10.1016\/j.ajpc.2025.101361_bib0109","doi-asserted-by":"crossref","DOI":"10.1186\/s12933-014-0123-x","article-title":"Association of metformin with lower atrial fibrillation risk among patients with type 2 diabetes mellitus: a population-based dynamic cohort and in vitro studies","volume":"13","author":"Chang","year":"2014","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.ajpc.2025.101361_bib0110","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.amjcard.2025.03.002","article-title":"The impact of sodium-glucose cotransporter-2 inhibitors on atrial fibrillation burden in diabetic patients","volume":"246","author":"Kidess","year":"2025","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1016\/j.ajpc.2025.101361_bib0111","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/FJC.0000000000001197","article-title":"Comparison of sodium\u2013Glucose cotransporter 2 inhibitors and glucagon-like peptide receptor agonists for atrial fibrillation in type 2 diabetes mellitus: systematic review with network meta-analysis of randomized controlled trials","volume":"79","author":"Li","year":"2022","journal-title":"J Cardiovasc Pharmacol"},{"issue":"19","key":"10.1016\/j.ajpc.2025.101361_bib0112","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1093\/eurheartj\/ehv728","article-title":"Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME \u00ae trial","volume":"37","author":"Fitchett","year":"2016","journal-title":"Eur Heart J"},{"issue":"9","key":"10.1016\/j.ajpc.2025.101361_bib0113","first-page":"e722","article-title":"Comprehensive management of cardiovascular risk factors for adults with type 2 diabetes: a scientific statement from the American Heart Association","volume":"145","author":"Joseph","year":"2022","journal-title":"Circ (N Y NY)"},{"issue":"10","key":"10.1016\/j.ajpc.2025.101361_bib0114","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.36307","article-title":"Racial and ethnic disparities in glycemic control among insured US adults","volume":"6","author":"Zakaria","year":"2023","journal-title":"JAMA netw open"},{"issue":"8","key":"10.1016\/j.ajpc.2025.101361_bib0115","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1001\/jama.2021.9883","article-title":"Trends in prevalence of diabetes and control of risk factors in diabetes among US adults, 1999-2018","volume":"326","author":"Wang","year":"2021","journal-title":"JAMA: j Am Med Assoc"},{"issue":"3","key":"10.1016\/j.ajpc.2025.101361_bib0116","first-page":"529","article-title":"Race and ethnic differences in glycemic control among adults with diagnosed diabetes in the United States","volume":"17","author":"Saydah","year":"2007","journal-title":"Ethn Dis"},{"key":"10.1016\/j.ajpc.2025.101361_bib0117","article-title":"Race and ethnicity and pharmacy dispensing of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes","volume":"34","author":"Rodriguez","year":"2024","journal-title":"Lancet Reg Health - Am (Online)"},{"issue":"1","key":"10.1016\/j.ajpc.2025.101361_bib0118","doi-asserted-by":"crossref","DOI":"10.1016\/j.xkme.2022.100564","article-title":"Disparities in SGLT2 inhibitor or glucagon-like peptide 1 receptor agonist initiation among medicare-insured adults with CKD in the United States","volume":"5","author":"Zhao","year":"2023","journal-title":"Kidney med"},{"issue":"9","key":"10.1016\/j.ajpc.2025.101361_bib0119","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1001\/jama.2022.13885","article-title":"Association of race and ethnicity with prescription of SGLT2 inhibitors and GLP1 receptor agonists among patients with type 2 diabetes in the Veterans Health Administration System","volume":"328","author":"Lamprea-Montealegre","year":"2022","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.ajpc.2025.101361_bib0120","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1002\/oby.24042","article-title":"Efficacy and safety of semaglutide 2.4\u2009mg by race and ethnicity: a post hoc analysis of three randomized controlled trials","volume":"32","author":"Rubino","year":"2024","journal-title":"Obes (Silver Spring Md)"},{"issue":"7","key":"10.1016\/j.ajpc.2025.101361_bib0121","article-title":"Nonmedical interventions for type 2 diabetes: evidence, actionable strategies, and policy opportunities","volume":"41","author":"Egede","year":"2022","journal-title":"Health aff (Millwood Va)"},{"key":"10.1016\/j.ajpc.2025.101361_bib0122","unstructured":"NIH. What is sleep apnea? 2025."},{"key":"10.1016\/j.ajpc.2025.101361_bib0123","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.hrtlng.2025.01.005","article-title":"Rising cardiovascular mortality among obstructive sleep apnea patients: united States epidemiological trends (1999\u20132019)","volume":"70","author":"Ali","year":"2025","journal-title":"Heart lung"},{"issue":"6","key":"10.1016\/j.ajpc.2025.101361_bib0124","article-title":"Racial disparities in obstructive sleep apnea care in the United States","volume":"48","author":"Acevedo-Fontanez","year":"2025","journal-title":"Sleep (N Y NY)"},{"issue":"6","key":"10.1016\/j.ajpc.2025.101361_bib0125","doi-asserted-by":"crossref","first-page":"841","DOI":"10.5664\/jcsm.11072","article-title":"Disparities in sleep care and cardiovascular outcomes: defining the problem and implementing solutions","volume":"20","author":"Healy","year":"2024","journal-title":"J clin sleep med"},{"issue":"5","key":"10.1016\/j.ajpc.2025.101361_bib0126","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/clc.22933","article-title":"The prevalence of obstructive sleep apnea in patients with atrial fibrillation","volume":"41","author":"Abumuamar","year":"2018","journal-title":"Clin cardiol (Mahwah NJ)"},{"issue":"20","key":"10.1016\/j.ajpc.2025.101361_bib0127","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1161\/01.CIR.0000068337.25994.21","article-title":"Obstructive sleep apnea and the recurrence of atrial fibrillation","volume":"107","author":"Kanagala","year":"2003","journal-title":"Circulation"},{"issue":"19","key":"10.1016\/j.ajpc.2025.101361_bib0128","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1056\/NEJMoa043104","article-title":"Obstructive sleep apnea as a risk factor for stroke and death","volume":"353","author":"Yaggi","year":"2005","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.ajpc.2025.101361_bib0129","first-page":"1699","article-title":"Associations between cardioembolic stroke and obstructive sleep apnea","volume":"38","author":"Lipford","year":"2015","journal-title":"Sleep (N Y NY)"},{"issue":"3","key":"10.1016\/j.ajpc.2025.101361_bib0130","doi-asserted-by":"crossref","first-page":"527","DOI":"10.3390\/jpm13030527","article-title":"Association of obstructive sleep apnea and atrial fibrillation in acute ischemic stroke: a cross-sectional study","volume":"13","author":"Brunetti","year":"2023","journal-title":"J Pers Med"},{"issue":"2","key":"10.1016\/j.ajpc.2025.101361_bib0131","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1161\/STROKEAHA.120.030285","article-title":"Impact of sleep apnea on cardioembolic risk in patients with atrial fibrillation: data from the ESADA cohort","volume":"52","author":"Pengo","year":"2021","journal-title":"Stroke (1970)"},{"issue":"12","key":"10.1016\/j.ajpc.2025.101361_bib0132","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/j.jacep.2020.05.030","article-title":"Prevalence of undiagnosed sleep apnea in patients with atrial fibrillation and its impact on therapy","volume":"6","author":"Shapira-Daniels","year":"2020","journal-title":"JACC Clin electrophysiol"},{"issue":"3","key":"10.1016\/j.ajpc.2025.101361_bib0133","article-title":"Atrial fibrillation in obstructive sleep apnea patients: mechanisms, risk factors, and management strategies","volume":"15","author":"Sankaranarayanan","year":"2023","journal-title":"Cur3us (Palo Alto CA)"},{"issue":"23","key":"10.1016\/j.ajpc.2025.101361_bib0134","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.010414","article-title":"A nurse-led limited risk factor modification program to address obesity and obstructive sleep apnea in atrial fibrillation patients","volume":"7","author":"Yaeger","year":"2018","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"10.1016\/j.ajpc.2025.101361_bib0135","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.tcm.2020.01.006","article-title":"Atrial fibrillation in obstructive sleep apnea: neural mechanisms and emerging therapies","volume":"31","author":"Huang","year":"2021","journal-title":"Trends Cardiovasc Med"},{"issue":"1","key":"10.1016\/j.ajpc.2025.101361_bib0136","article-title":"The impact of continuous positive airway pressure on cardiac arrhythmias in patients with sleep apnea","volume":"25","author":"Varga","year":"2020","journal-title":"J res med sci"},{"issue":"6","key":"10.1016\/j.ajpc.2025.101361_bib0137","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000421","article-title":"Effect of sleep apnea and continuous positive airway pressure on cardiac structure and recurrence of atrial fibrillation","volume":"2","author":"Neilan","year":"2013","journal-title":"J Am Heart Assoc"},{"issue":"5","key":"10.1016\/j.ajpc.2025.101361_bib0138","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.ahj.2014.12.024","article-title":"Impact of obstructive sleep apnea and continuous positive airway pressure therapy on outcomes in patients with atrial fibrillation\u2014Results from the Outcomes Registry for better informed treatment of atrial fibrillation (ORBIT-AF)","volume":"169","author":"Holmqvist","year":"2015","journal-title":"Am heart j"},{"issue":"3","key":"10.1016\/j.ajpc.2025.101361_bib0139","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s10840-018-0482-4","article-title":"Cardiac effects of CPAP treatment in patients with obstructive sleep apnea and atrial fibrillation","volume":"54","author":"Abumuamar","year":"2019","journal-title":"J interv card electrophysiol"},{"issue":"12","key":"10.1016\/j.ajpc.2025.101361_bib0140","first-page":"1653","article-title":"Race and residential socioeconomics as predictors of CPAP adherence","volume":"34","author":"Billings","year":"2011","journal-title":"Sleep (N Y NY)"},{"issue":"4","key":"10.1016\/j.ajpc.2025.101361_bib0141","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1055\/s-2004-860894","article-title":"Racial differences in clinical presentation of patients with sleep-disordered breathing","volume":"8","author":"Scharf","year":"2004","journal-title":"Sleep breath"},{"issue":"2","key":"10.1016\/j.ajpc.2025.101361_bib0142","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1513\/AnnalsATS.202012-1483OC","article-title":"Differences in symptoms and severity of obstructive sleep apnea between black and white patients","volume":"19","author":"Thornton","year":"2022","journal-title":"Ann Am Thorac Soc"},{"issue":"4","key":"10.1016\/j.ajpc.2025.101361_bib0143","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.ahj.2012.12.018","article-title":"Obstructive sleep apnea and cardiovascular disease in blacks: a call to action from the Association of Black Cardiologists","volume":"165","author":"Olafiranye","year":"2013","journal-title":"Am heart j"},{"key":"10.1016\/j.ajpc.2025.101361_bib0144","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ijcard.2017.05.133","article-title":"Alcohol and incident atrial fibrillation \u2013 A systematic review and meta-analysis","volume":"246","author":"Gallagher","year":"2017","journal-title":"Int J Cardiol"},{"issue":"1","key":"10.1016\/j.ajpc.2025.101361_bib0145","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa1817591","article-title":"Alcohol abstinence in drinkers with atrial fibrillation","volume":"382","author":"Voskoboinik","year":"2020","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.ajpc.2025.101361_bib0146","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.hrtlng.2020.12.009","article-title":"National rates and trends of tobacco and substance use disorders among atrial fibrillation hospitalizations","volume":"50","author":"Doshi","year":"2021","journal-title":"Heart lung"},{"issue":"11","key":"10.1016\/j.ajpc.2025.101361_bib0147","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.7326\/M21-0228","article-title":"Acute consumption of alcohol and discrete atrial fibrillation events","volume":"174","author":"Marcus","year":"2021","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ajpc.2025.101361_bib0148","article-title":"Alcohol use and cardiovascular disease: a scientific statement from the American Heart Association","author":"Piano","year":"2025","journal-title":"Circ (N Y NY)"},{"issue":"4","key":"10.1016\/j.ajpc.2025.101361_bib0149","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jacc.2010.08.641","article-title":"Alcohol consumption and risk of atrial fibrillation: a meta-analysis","volume":"57","author":"Kodama","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.ajpc.2025.101361_bib0150","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jacc.2014.03.048","article-title":"Alcohol consumption and risk of atrial fibrillation: a prospective study and dose-response meta-analysis","volume":"64","author":"Larsson","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.ajpc.2025.101361_bib0151","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.004060","article-title":"Alcohol consumption, left atrial diameter, and atrial fibrillation","volume":"5","author":"McManus","year":"2016","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"10.1016\/j.ajpc.2025.101361_bib0152","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.hrthm.2018.10.041","article-title":"Moderate alcohol consumption is associated with atrial electrical and structural changes: insights from high-density left atrial electroanatomic mapping","volume":"16","author":"Voskoboinik","year":"2019","journal-title":"Heart rhythm"},{"issue":"11","key":"10.1016\/j.ajpc.2025.101361_bib0153","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002349","article-title":"Impact of alcohol consumption on substrate remodeling and ablation outcome of paroxysmal atrial fibrillation","volume":"4","author":"Qiao","year":"2015","journal-title":"J Am Heart Assoc"},{"issue":"46","key":"10.1016\/j.ajpc.2025.101361_bib0154","doi-asserted-by":"crossref","first-page":"4759","DOI":"10.1093\/eurheartj\/ehab315","article-title":"Lower risk of stroke after alcohol abstinence in patients with incident atrial fibrillation: a nationwide population-based cohort study","volume":"42","author":"Lee","year":"2021","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.ajpc.2025.101361_bib0155","doi-asserted-by":"crossref","DOI":"10.1186\/s12872-025-05122-8","article-title":"Global burden of atrial fibrillation and atrial flutter due to high alcohol use from 1990 to 2021: estimates from the global burden of disease study 2021","volume":"25","author":"Wang","year":"2025","journal-title":"BMC Cardiovasc Disord"},{"issue":"17","key":"10.1016\/j.ajpc.2025.101361_bib0156","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1056\/NEJMcp2402121","article-title":"Addressing alcohol use","volume":"392","author":"Krist","year":"2025","journal-title":"N Engl J Med"},{"issue":"17","key":"10.1016\/j.ajpc.2025.101361_bib0157","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1001\/jama.2023.19761","article-title":"Pharmacotherapy for Alcohol use disorder: a systematic review and meta-analysis","volume":"330","author":"McPheeters","year":"2023","journal-title":"JAMA: j Am Med Assoc"},{"issue":"4","key":"10.1016\/j.ajpc.2025.101361_bib0158","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1001\/jamapsychiatry.2024.4789","article-title":"Once-weekly semaglutide in adults with alcohol use disorder: a randomized clinical trial","volume":"82","author":"Hendershot","year":"2025","journal-title":"JAMA psychiatry (Chic Ill)"},{"issue":"10","key":"10.1016\/j.ajpc.2025.101361_bib0159","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0185228","article-title":"Past alcohol consumption and incident atrial fibrillation: the Atherosclerosis risk in Communities (ARIC) study","volume":"12","author":"Dixit","year":"2017","journal-title":"PloS one"},{"issue":"11","key":"10.1016\/j.ajpc.2025.101361_bib0160","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1176\/appi.ajp.20230730","article-title":"Disparities in treatment for alcohol use disorder among all of us participants","volume":"181","author":"Le","year":"2024","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.ajpc.2025.101361_bib0161","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108569","article-title":"Drug and alcohol treatment utilization and barriers among black, American Indian\/Alaskan Native, Latine, Asian\/Pacific Islander\/Native Hawaiian, and white adults: findings from NESARC-III","volume":"131","author":"Haeny","year":"2021","journal-title":"J Subst Abuse Treat"},{"issue":"1","key":"10.1016\/j.ajpc.2025.101361_bib0162","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/acer.13285","article-title":"Alcohol use disorder, and treatment access and utilization among U.S. Racial\/ethnic groups","volume":"41","author":"Vaeth","year":"2017","journal-title":"Alcohol clin exp res"},{"key":"10.1016\/j.ajpc.2025.101361_bib0163","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.drugalcdep.2019.05.017","article-title":"A current re-examination of racial\/ethnic disparities in the use of substance abuse treatment: do disparities persist?","volume":"202","author":"Pinedo","year":"2019","journal-title":"Drug Alcohol Depend"},{"issue":"5","key":"10.1016\/j.ajpc.2025.101361_bib0164","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/alcalc\/agad024","article-title":"Risky drinking and other drug use in adults with chronic conditions in the United States: differential associations by race\/ethnicity","volume":"58","author":"Cook","year":"2023","journal-title":"Alcohol alcohol (Oxf)"},{"issue":"1","key":"10.1016\/j.ajpc.2025.101361_bib0165","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/00952990.2023.2296860","article-title":"A scoping review of health inequities in alcohol use disorder","volume":"50","author":"Ward","year":"2024","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"13","key":"10.1016\/j.ajpc.2025.101361_bib0166","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1177\/2047487318780435","article-title":"Tobacco smoking and the risk of atrial fibrillation: a systematic review and meta-analysis of prospective studies","volume":"25","author":"Aune","year":"2018","journal-title":"Eur J Prev Cardiol"},{"issue":"18","key":"10.1016\/j.ajpc.2025.101361_bib0167","doi-asserted-by":"crossref","first-page":"475","DOI":"10.15585\/mmwr.mm7218a1","article-title":"Tobacco product use among adults \u2013 United States, 2021","volume":"72","author":"Cornelius","year":"2023","journal-title":"MMWR Morb mortal wkly rep"},{"issue":"3","key":"10.1016\/j.ajpc.2025.101361_bib0168","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1378\/chest.13-1740","article-title":"The impact of smoking on thromboembolism and mortality in patients with incident atrial fibrillation","volume":"145","author":"Albertsen","year":"2014","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.ajpc.2025.101361_bib0169","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.annepidem.2014.11.024","article-title":"Atrial fibrillation incidence and risk factors in relation to race-ethnicity and the population attributable fraction of atrial fibrillation risk factors: the Multi-Ethnic Study of Atherosclerosis","volume":"25","author":"Rodriguez","year":"2015","journal-title":"Ann Epidemiol"},{"issue":"8","key":"10.1016\/j.ajpc.2025.101361_bib0170","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.hrthm.2011.03.038","article-title":"Smoking and incidence of atrial fibrillation: results from the Atherosclerosis risk in Communities (ARIC) study","volume":"8","author":"Chamberlain","year":"2011","journal-title":"Heart Rhythm"},{"issue":"9","key":"10.1016\/j.ajpc.2025.101361_bib0171","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1136\/hrt.2005.087171","article-title":"Cigarette smoking induces atrial fibrosis in humans via nicotine","volume":"93","author":"Goette","year":"2007","journal-title":"Heart"},{"issue":"3","key":"10.1016\/j.ajpc.2025.101361_bib0172","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.ijcard.2009.03.110","article-title":"Atrial fibrosis and atrial fibrillation: the role of the TGF-\u03b21 signaling pathway","volume":"143","author":"Gramley","year":"2010","journal-title":"Int J Cardiol"},{"issue":"3","key":"10.1016\/j.ajpc.2025.101361_bib0173","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1093\/cvr\/cvp130","article-title":"Downregulation of miR-133 and miR-590 contributes to nicotine-induced atrial remodelling in canines","volume":"83","author":"Shan","year":"2009","journal-title":"Cardiovasc Res"},{"issue":"26","key":"10.1016\/j.ajpc.2025.101361_bib0174","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.2174\/1381612824666180903144042","article-title":"Mechanisms and treatments of oxidative stress in atrial fibrillation","volume":"24","author":"Ren","year":"2018","journal-title":"Curr Pharm Des"},{"issue":"3","key":"10.1016\/j.ajpc.2025.101361_bib0175","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1177\/1741826711411738","article-title":"Nicotine, cigarette smoking and cardiac arrhythmia: an overview","volume":"19","author":"D'Alessandro","year":"2012","journal-title":"Eur J Prev Cardiol"},{"issue":"5","key":"10.1016\/j.ajpc.2025.101361_bib0176","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/jce.12936","article-title":"Catheter ablation for \"lone\" atrial fibrillation: efficacy and predictors of recurrence","volume":"27","author":"Buiatti","year":"2016","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"5","key":"10.1016\/j.ajpc.2025.101361_bib0177","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/jce.13451","article-title":"Cigarette smoking causes a worse long-term outcome in persistent atrial fibrillation following catheter ablation","volume":"29","author":"Cheng","year":"2018","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"5","key":"10.1016\/j.ajpc.2025.101361_bib0178","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1378\/chest.13-0054","article-title":"Factors affecting quality of anticoagulation control among patients with atrial fibrillation on warfarin: the SAMe-TT\u2082R\u2082 score","volume":"144","author":"Apostolakis","year":"2013","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.ajpc.2025.101361_bib0179","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-020-8275-y","article-title":"Association of smoking cessation after atrial fibrillation diagnosis on the risk of cardiovascular disease: a cohort study of South Korean men","volume":"20","author":"Choi","year":"2020","journal-title":"BMC public health"},{"issue":"1","key":"10.1016\/j.ajpc.2025.101361_bib0180","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/cvr\/cvaa344","article-title":"Stroke risk prediction in patients with atrial fibrillation with and without rheumatic heart disease","volume":"118","author":"Benz","year":"2022","journal-title":"Cardiovasc Res"},{"issue":"8","key":"10.1016\/j.ajpc.2025.101361_bib0181","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.jchf.2017.04.004","article-title":"Modifiable risk factors for incident heart failure in atrial fibrillation","volume":"5","author":"Chatterjee","year":"2017","journal-title":"JACC Heart fail"},{"key":"10.1016\/j.ajpc.2025.101361_bib0182","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ahj.2016.11.008","article-title":"Multimorbidity and the risk of hospitalization and death in atrial fibrillation: a population-based study","volume":"185","author":"Chamberlain","year":"2017","journal-title":"Am Heart J"},{"issue":"3","key":"10.1016\/j.ajpc.2025.101361_bib0183","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1378\/chest.13-1740","article-title":"The impact of smoking on thromboembolism and mortality in patients with incident atrial fibrillation","volume":"145","author":"Albertsen","year":"2014","journal-title":"Chest"},{"issue":"13","key":"10.1016\/j.ajpc.2025.101361_bib0184","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.011307","article-title":"Provider-level variation in smoking cessation assistance provided in the cardiology clinics: insights from the NCDR PINNACLE Registry","volume":"8","author":"Sardana","year":"2019","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"10.1016\/j.ajpc.2025.101361_bib0185","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1136\/tobaccocontrol-2011-050124","article-title":"Who receives prescriptions for smoking cessation medications? An association rule mining analysis using a large primary care database","volume":"22","author":"Huang","year":"2013","journal-title":"Tob Control"},{"key":"10.1016\/j.ajpc.2025.101361_bib0186","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.pcad.2022.04.009","article-title":"Current state of unhealthy living characteristics in Black\/African American and Latino populations: tobacco use","volume":"71","author":"Sabado-Liwag","year":"2022","journal-title":"Prog Cardiovasc Dis"},{"issue":"5","key":"10.1016\/j.ajpc.2025.101361_bib0187","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.amepre.2008.02.003","article-title":"Racial and ethnic disparities in smoking-cessation interventions: analysis of the 2005 National Health Interview Survey","volume":"34","author":"Cokkinides","year":"2008","journal-title":"Am J Prev Med"},{"issue":"5","key":"10.1016\/j.ajpc.2025.101361_bib0188","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.4585","article-title":"National trends in cessation counseling, prescription medication use, and associated costs among US adult cigarette smokers","volume":"2","author":"Tibuakuu","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"8","key":"10.1016\/j.ajpc.2025.101361_bib0189","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.2105\/AJPH.2018.304492","article-title":"Disparities in smoking cessation assistance in US primary care clinics","volume":"108","author":"Bailey","year":"2018","journal-title":"Am j public health (1971)"},{"issue":"1","key":"10.1016\/j.ajpc.2025.101361_bib0190","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.32053","article-title":"Assessment of racial differences in pharmacotherapy efficacy for smoking cessation: secondary analysis of the EAGLES randomized clinical trial","volume":"4","author":"Nollen","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"11","key":"10.1016\/j.ajpc.2025.101361_bib0191","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.3390\/jcm10112238","article-title":"Smoking cessation after diagnosis of new-onset atrial fibrillation and the risk of stroke and death","volume":"10","author":"Lee","year":"2021","journal-title":"J Clin Med"},{"issue":"2","key":"10.1016\/j.ajpc.2025.101361_bib0192","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1001\/jamacardio.2022.4091","article-title":"Transforming atrial fibrillation research to integrate social determinants of health: a National Heart, Lung, and Blood Institute workshop report","volume":"8","author":"Benjamin","year":"2023","journal-title":"JAMA cardiol"},{"issue":"18","key":"10.1016\/j.ajpc.2025.101361_bib0193","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMoa2501440","article-title":"Lorundrostat efficacy and safety in patients with uncontrolled hypertension","volume":"392","author":"Laffin","year":"2025","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ajpc.2025.101361_bib0194","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1056\/NEJMoa2208391","article-title":"Zilebesiran, an RNA interference therapeutic agent for hypertension","volume":"389","author":"Desai","year":"2023","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.ajpc.2025.101361_bib0195","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1377\/hlthaff.2016.0029","article-title":"Removing obstacles to eliminating racial and ethnic disparities In behavioral health care","volume":"35","author":"Alegr\u00eda","year":"2016","journal-title":"Health Aff"},{"issue":"1","key":"10.1016\/j.ajpc.2025.101361_bib0196","doi-asserted-by":"crossref","first-page":"7","DOI":"10.15288\/jsad.2018.79.7","article-title":"The future of research on alcohol-related disparities across U.S. Racial\/ethnic groups: a plan of attack","volume":"79","author":"Zemore","year":"2018","journal-title":"J Stud Alcohol Drugs"},{"issue":"15","key":"10.1016\/j.ajpc.2025.101361_bib0197","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/j.jacc.2023.02.002","article-title":"Out-of-pocket drug costs for Medicare beneficiaries with cardiovascular risk factors under the inflation Reduction Act","volume":"81","author":"Narasimmaraj","year":"2023","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.ajpc.2025.101361_bib0198","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1056\/NEJMra2306511","article-title":"Identification and treatment of Alcohol use disorder","volume":"392","author":"Haber","year":"2025","journal-title":"N Engl J Med"}],"container-title":["American Journal of Preventive Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666667725004362?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666667725004362?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T04:40:28Z","timestamp":1775104828000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666667725004362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":198,"alternative-id":["S2666667725004362"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpc.2025.101361","relation":{},"ISSN":["2666-6677"],"issn-type":[{"value":"2666-6677","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Racial and ethnic disparities in the management of risk factors in individuals with atrial fibrillation: A narrative review","name":"articletitle","label":"Article Title"},{"value":"American Journal of Preventive Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpc.2025.101361","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101361"}}